Qualification | Year | Awarding Institution | Department |
MD | 1984-1991 | Aristoteleio University Greece | Medical School of Aristotle’s |
Specialist Neurologist | 1995 | Aristoteleio University Greece | Medical School of Aristotle’s |
Period of employment | Employer | Location | Position | |
From | To | |||
2102 | Today | The Cyprus School of Molecular Medicine, CING | Cyprus | Associate Professor |
2007 | Today | The Cyprus Institute of Neurology and Genetics | Cyprus | Director of Neurology |
1995 |
2007 | The Cyprus Institute of Neurology and Genetics | Nicosia, Cyprus | Head of the Multiple Sclerosis Clinic of the CING |
Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
2016 Jul | The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis | Filippidou N, Krashias G, Pericleous C, Rahman A, Ioannou Y, Giles I, Demetriou C, Anatolitou A, Christodoulou C, Pantzaris M, Lambrianides A | 75:161-7 | ||
2015 | ‘Evaluation of the safety, efficacy and retention of Mitoxantrone in Cypriot patient with Primary Progressive Multiple Sclerosis’. Published in “European Journal of Neurology”, | E. Kkolou, E. Gaglia, J. Toufexis, M. Pantzaris. | vol.22, supp. 1 | ||
July 21, 2015. | "A comparison of ultrasound intima-media thickness measurements of the left and right common carotid artery," IEEE J.Translational | C.P. Loizou, A.N. Nicolaides, N. Georghiou, M. Pantziaris, M. Griffin, E. Kyriakou, C.S. Pattichis | vol. 3 | pp. 1-10 | |
2015 | "An integrated system for the complete segmentation of the common carotid artery bifurcation in ultrasound images," J. Biomed. Eng. & Informatics, | C.P. Loizou, M. Pantziaris, | vol. 1 | pp. 11-24 | |
2015 | An effective ultrasound video communication system using despeckle filtering and HEVC," IEEE | A.S. Panayides, M.S. Pattichis, C.P. Loizou, M. Pantziaris, A.G. Constantinides, C.S. Pattichis | vol. 19 | pp. 668-676 |
Date | Title | Funded by |
2015-2017 | PLP10 in Parkinson Disease | Ministry of Commerce, Industry and Tourism. |
2013-2015 | Multicenter, randomized, double blind, placebo controlled clinical trial for the treatment of Multiple Sclerosis with a new prototype pioneer neutraceutical formulation (PLP10) ( Mineral Study) Ministry of Commerce, Industry and Tourism Program for the creation of New High Technology and Innovation Enterprises through the Business Incubator | Ministry of Commerce, Industry and Tourism. |
2010-2012 | A study of modifier genes on disease severity n Multiple Sclerosis | Funded by Cyprus Research Promotion Foundation (RPF) |
2009-2011 | Identification of distinct microRNA profiles in Multiple Sclerosis patients resistance to Interferon-beta (IFN-β) | Funded by a “Genesis Pharma Cyprus” Grand |
2009-2011 | Study of amending genes in the prognosis of multiple sclerosis severity | Funded by a “Genesis Pharma Cyprus” Grand |